Related Experiment Video
Updated: Jul 25, 2025
10:41
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
14.1K
Tuberculosis in the European Region
Jessica Mencarini1, Michele Spinicci1,2, Lorenzo Zammarchi1,2
1SOD Malattie Infettive e Tropicali, AOU Careggi, Florence, Italy.
Current Tropical Medicine Reports
|June 26, 2023
Summary
Tuberculosis (TB) epidemiology in Europe is impacted by the COVID-19 pandemic and migration. New short treatment regimens and preventive strategies offer hope for reducing TB incidence and public health impact.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- Tuberculosis (TB) is a significant global public health issue.
- Factors like the COVID-19 pandemic, migration, climate change, and geopolitical conflicts are influencing TB epidemiology in Europe.
- These factors disrupt healthcare access and drug availability, particularly in high-prevalence areas.
Purpose of the Study:
- To review current data on TB in Europe.
- To examine new findings in TB treatment and prevention strategies.
- To understand the impact of recent global events on TB control.
Main Methods:
- Literature review of recent data on TB in Europe.
- Analysis of the influence of COVID-19 and migration on TB epidemiology.
- Evaluation of emerging treatment and prevention strategies.
Main Results:
- The COVID-19 pandemic hindered healthcare access and patient retention, affecting TB diagnosis and incidence.
- European conflicts have reduced access to TB services and drugs, increasing refugee migration.
- Emerging data on shorter treatment regimens may alter therapy duration and side effect profiles.
Conclusions:
- TB control programs face evolving challenges that could alter future TB incidence.
- Novel antibiotic approaches and enhanced preventive policies present opportunities to mitigate TB's public health burden.
- Adapting strategies to current global dynamics is crucial for effective TB control.
More Related Videos
Related Concept Videos
01:26Pulmonary Tuberculosis IV
175
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
175
01:29Pulmonary Tuberculosis I
286
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
286
01:28Pulmonary Tuberculosis V
214
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
214
01:28Pulmonary Tuberculosis II
281
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
281
01:31Pulmonary Tuberculosis III
381
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
381
01:17Other Pulmonary Disorders
875
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
875